Skip to content

Clinical trials

Completed Phase 2 Retinal Vein Occlusion trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Vein Occlusion Phase: Phase 2 Status: Completed Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20091
20101
20131
20153
20171
20192
20212
20221
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.2
Aerie Pharmaceuticals1
Aerpio Therapeutics1
Allergan1
Annexin Pharmaceuticals AB1
Barnes Retina Institute1
Clearside Biomedical, Inc.1
Eyetech Pharmaceuticals1
Novartis Pharmaceuticals1
Retina Associates of Florida, P.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Vein Occlusion17
Macular Edema9
Diabetic Retinopathy3
Macular Degeneration3
Wet Macular Degeneration2
Diabetes Mellitus1
Geographic Atrophy1
Retinal Diseases1
Retinal Neovascularization1
Uveitis1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.